Commission report finds active competition enforcement continues to contribute to affordable and innovative medicines

Critical medicines: EU measures to boost competitiveness and tackle shortages 

This article is brought to you in association with the European Commission. The European Commission has published a report providing an overview of the enforcement of EU antitrust and merger rules by the Commission and the national competition authorities (‘NCAs’) in the pharmaceutical sector between 2018 and 2022. Today’s report shows that active enforcement of antitrust […]

Go back up